Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of sulfonamides for treatment of endothelin-mediated disorders

Formulation of sulfonamides for treatment of endothelin-mediated disorders

US Patent 6458805 · Granted Oct 1, 2002

Estimated economic value: $2,197,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SGLT2/DPP4 inhibitor and application thereof2025
Spiro compound serving as ERK inhibitor, and application thereof2025
SGLTS/DPP4 inhibitor and application thereof2025
BRD4 inhibitor compound in solid form and preparation method therefor and use th2025
Glucoside derivative that acts as SGLT1 inhibitor and application thereof2025
Macrocyclic derivatives acting as XIa factor inhibitor2024
Diarylthiohydantoin compound as androgen receptor antagonist2024
Heterocyclic compound2023
Crystal form as ASK1 inhibitor and preparation method and application thereof2023
Furin inhibitors2023
Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors2023
Five-membered heteroaryl-fused imidazole compound and application thereof2023